Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Analyzing Psychological Disorders 1 Running Head: ANALYZING PSYCHOLOGICAL DISORDERS Analyzing Psychological Disorders Analyzing Psychological Disorders 2 Analyzing Psychological Disorders Introduction The biological approach to psychology dominates treatments in the field of Biopsychology. Psychological diseases and disorders are diagnosed from the physiological point of view. This paper will include an analysis of the psychological disorder called Schizophrenia. I will consider the brain areas affecting and affected by the disorder, the possible causal factors, the characteristic symptoms, the neural basis and the accepted drug treatments. I will also review the Generalized Anxiety Disorder and the eating disorder, Anorexia Nervosa. These last two disorders will be considered in relation to nature/nurture and theories of etiology. Accepted drug therapies and alternative treatments for these disorders will also be discussed. Part A: Schizophrenia This condition is one of the most complicated disorders that humans exhibit. Its name comes from the symptoms which indicate that there is a “splitting of psychic functions (Pinel, 2007, p.481)”. Symptoms of schizophrenia include, in varying severity and combinations, hallucinations, grossly disorganized or catatonic behavior patterns and negative symptoms, delusions and disorganized or incoherent speech (American Analyzing Psychological Disorders 3 Psychiatric Association, 2000). Due to the severity of these symptoms, sufferers are usually socially and occupationally dysfunctional. Diagnosis is based on the persistent combination of function impairment and symptoms for a period of 6 months (American Psychiatric Association, 2000). Causal Theories and Neural Basis A number of theories have been put forth regarding causal factors in schizophrenic development. There is a strong body of evidence that indicates the disorder may have genetic links, especially to first degree relatives who have been diagnosed as schizophrenic (Pinel, 2007). This genetic component seems to be combined with early trauma and stress that can trigger development of the disorder. Neurodevelopment impairment early in life due to infection, autoimmune reactions and toxin exposure may also contribute to later development of this disorder (Pinel, 2007). Other theories hold that individuals who suffer from schizophrenia have increased levels of the brain chemical dopamine. This theory was developed during Parkinson’s disease research when the drug chlorpromazine was shown to be a receptor blocker (Pinel, 2007). The dopamine theory was advanced when the D2 receptors were found to be reactive to phenothiazines and butyrophenones. Phenothiazines bind to both D1 and D2 receptors. receptors. Butyrophenones bind to D2 It was revealed that hyperactivity at the D2 receptor site and not all dopamine receptor sites was evident in schizophrenia (Pinel, 2007). Analyzing Psychological Disorders 4 Additional research has recently shown that Schizophrenia may be connected to other brain factors. Atypical neuroleptic drugs which do not act as D2 blockers may have effects when given for prolonged periods of two weeks or more. These drugs include clozapine which shows a negligible effect on the D2 receptors but exhibits an increased effect on other brain receptors (D1, D4 and multiple serotonin receptors) (Pinel, 2007). The prolonged administration is required in spite of the fact that neuroleptic drug therapy effectively blocks D2 receptors within just a few hours of administration. This suggests that D receptors are not a key factor in this disorders’ etiology (Pinel, 2007). These neuroleptic therapies do not provide relief for all individuals who are diagnosed as schizophrenic. The neuroleptic drugs have proven to be most effective in treating incoherence, hallucinations and delusions. They are less effective in alleviating negative symptoms that are related to affect, cognitive deficits and speech dysfunction. Thus, the D2 theory of hyperactivity at the receptor site is not strongly supported by this conflicting treatment success (Pinel, 2007). Brain imaging studies contribute information to the etiology of schizophrenia. Brain abnormalities in the small cerebral cortex and enlarged cerebral ventricles are seen in these patients (Pinel, 2007). These studies give further credence to the theory that neural development issues contribute to the development of this disorder. There is also abnormal brain laterality that cannot be explained by the dopamine theory (Pinel, 2007). Appropriate Drug Therapies Analyzing Psychological Disorders 5 Group, family and psychotherapy are used to increase the success of schizophrenic treatments. However, these therapies must be used in conjunction with other effective drug therapies to be of use in treating the complex of symptoms are experienced in this disorder (Grohol, 2008). that Combinations of antipsychotic, antidepressant and anti anxiety medications may be used to address the entire range of symptoms in a patient (Grohol, 2008). Patients are very likely to discontinue their medications due to side effects and/or ineffectiveness, so they must be monitored to determine that the therapy is appropriate for that patient (Grohol, 2008). Appropriate patient education must also be used to reduce the possible side effects and so that the proper dosage and length of treatment course are followed. Patient education also must include coping strategies that are appropriate for the side effects of any treatment. Treatment plans must be carefully designed to take into account each patient’s current illness, target symptoms, age, medical history, compliance abilities and interaction cautions for other drugs that they may be taking (Bailey, 1998). The patient’s progress must be monitored throughout the course of treatment to ensure responsiveness to treatment, dosage adjustments, patient compliance and tolerance to any side effects (Bailey, 1998). Schizophrenic individuals have shown the best responses to Clozapine as a pharmaceutical treatment option, more so than to newer antipsychotic medications (Grohol, 2008). Most antipsychotic medications have a high risk of serious side effects. Therefore, patients must be monitored throughout the course of their treatment when Analyzing Psychological Disorders 6 these medications are used. Side effects of antipsychotic medications include central nervous dysfunction, sedation, visual disturbances, gastrointestinal complaints, skin discoloration, photosensitivity, reduced ability to sweat and possible allergic reactions. These side effects vary in their severity and duration (Bailey, 1998). Part B: Case Studies on Anorexia Nervosa and Generalized Anxiety Disorder I received two case studies for biopsychological analysis. I was asked to examine the case study disorders with consideration of the nature-nurture debate and to evaluate the advantages of any drug therapies for each of these cases. Case A is a young woman who has been diagnosed with Anorexia Nervosa. Case B is an individual who suffers from anxiety (Axia College, n.d.). Case A: Anorexia Nervosa (Restricting Type) Case A’s patient is named Beth. She became obsessed in her teen years by fear of weight gain. This happened even though she was, at the time, of normal weight for her age and height. Her response to this fear was to diet. She lost half her body weight without gaining any benefit to her self-image. Her current weight is “dangerously thin”, yet she continues to lose weight. Her weight is so low that she experiences amenorrhea (Axia College, n.d.). I would make the diagnosis for Beth of Anorexia Nervosa (Restricting Type) (American Psychiatric Association, 2000). Her disorder became out of control during her early dieting. The unreasonable fear of the weight was the initial motivation for the dieting, but she did not respond to Analyzing Psychological Disorders 7 weight loss by beginning to eat normally once she had lost weight. Studies have found that adolescent females begin to diet as a direct response to social cues that dictate physical attractiveness and acceptable weight limits that are unreasonable and untenable. They often develop this disorder if their personality exhibits highly controlled, rigid or obsessive behaviors (Pinel, Assanand, & Lehman, 2000). Anorexia Nervosa may develop in due to negative incentive values becoming ascribed to food. This is another element that provides insight to this disorders’ development. There is much confusion about the etiology of this disorder. The role of negative or positive incentives surrounding food has not been made clear for these individuals. Anorexics are generally obsessed with food, spending inordinate amounts of time in food preparation or thinking and talking about food (Pinel, Assanand, & Lehman, 2000). This would seem to indicate that food has some positive incentive value for the anorexic. But this behavior does not necessarily indicate positive incentive since the anorexic does not usually eat these foods, or binges and purges. They relate food intake directly with weight gain, not with health and sustenance. Therefore, the food is not seen in a positive incentive light. Food intake is not related to positive incentive value in the anorexic person so they restrict their food intake (Pinel, 2007). This particular eating disorder is devastating to both the sufferer and to their families. The patient is literally starving themselves to death. This condition is very Analyzing Psychological Disorders 8 resistant to any treatment modality (Pinel, Assanand, & Lehman, 2000). Causal factors can vary greatly in this disorder from one individual to another. Clues to the etiology of anorexic patients may lie in an examination of their naturenurture history. Beth’s genetic makeup may leave her at risk for this particular disease. There are a number of such factors that are common in anorexics. Nurture can also be a contributing factor. Family environment and social environment both can play significant roles in the development of this disease. Psychotherapy would be indicated to determine if pharmacological treatments would be indicated in this case. In general, it has been found that pharmacological methods show little or no effectiveness for anorexia treatment. included tricyclic antidepressants. (Barbarich-Marstellar, 2007). Those methods examined for this use have These inhibit norepinephrine and 5-HT uptake Disappointing results have come from prescription of selective serotonin reuptake inhibitors in acute phase treatment of this disease and also are not found to be effective in relapse prevention (Barbarich-Marstellar, 2007). Classic antipsychotics are known to result in weight gain as a side effect so anorexic patients typically will refuse treatment with this class of drugs (Barbarich-Marstellar, 2007). Case B: Anxiety (Generalized Anxiety Disorder) This case is of a man named Tom. He is professionally successful and has three children and a wife (Axia College, n.d.). On external examination, his life seems remarkably stable and fulfilling. However, Tom presents with the signs and symptoms Analyzing Psychological Disorders 9 of Generalized Anxiety Disorder. He meets all the criteria of the American Psychiatric Association’s for this diagnosis, since he exhibits excessive worry about his health, finances, and job responsibilities that are not in keeping with the reality of his situation. He has presented with these symptoms having been chronic for over 6 months (American Psychiatric Association, 2000). His anxiety has begun to interfere with his performance at work and his personal life. The physical symptoms of Generalized Anxiety Disorder have manifested for him as muscle tension, headaches, hot flashes, nausea, and fatigue. His sleep is regularly disturbed and he is irritable and has difficulty concentrating (Axia College, n.d.). I would make the complete diagnosis of Generalized Anxiety Disorder. This disorder character is expressed in an overall anxiety which occurs in the absence of obvious causal factors (Pinel, 2007). The genetic component of this disorder is significant. There are theories about this disorder that indicate that it is experiential rather than due to faulty neural functioning (Pinel, 2007). Nurture seems to be a very salient factor in the development of this disorder. It is remarkable in discussing this disorder that fear and anxiety are found in studies to be guided by different brain mechanisms (“Fear and anxiety: A simultaneous concept analysis,” 1999). Fear is an emotion directly regulated and connected to the amygdale. Anxiety is connected to the hippocampus (“Fear and anxiety: A simultaneous concept analysis,” 1999). Analyzing Psychological Disorders 10 Benzodiazepines and serotonin agonists are most often prescribed as treatments for these types of anxiety disorders. The intent of this treatment is the reduction of the symptoms of anxiety (Pinel, 2007). Benzodiazepines are used widely in psychological treatment plans, but they have high risk of addiction. Side effects also include tremors, sedation, motor activity disruption and nausea. The effects of withdrawal can be extreme (Pinel, 2007). This class of drugs is more beneficial for patients who have one of the other anxiety disorder diagnoses. My recommendation for Tom would be a course of serotonin agonist. Buspirone may be useful for this treatment as it can reduce his anxiety without giving him side effects that are associated with the benzodiazepines. Serotonin agonists side effects include headache, dizziness, nausea and possible sleep disturbances. These effects do tend to diminish with continued use (Pinel, 2007). With counseling, he may manage the initial side effects if they are not too severe. The benefits outweigh the long term effects of the disorder itself (Pinel, 2007). Conclusion Each psychiatric disorder and disease is characterized by its own set of unique symptoms. They range in severity from mild to extreme. Causes and contributing factors of these disorders and diseases include genetics, neurodevelopment issues, brain damage and experience in various combinations. Generalized Anxiety Disorder and Anorexia Nervosa are quite common and both are difficult to understand. The Analyzing Psychological Disorders 11 biological factors that can contribute to the onset, development and course of psychological illness must be taken into account. Neural functioning and the role of brain structures in behavior and thought processing can shed further light on an individual’s disease process and prognosis. There are common threads in psychiatric disorders in that they all cause the sufferer a great deal of personal distress. Treatments vary widely in their success. With additional research and study into the causes and treatment modalities, it may be possible for many people who suffer from these disorders to enjoy brighter futures. Analyzing Psychological Disorders 12 References American Psychiatric Association, (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Jaypee Brothers Medical Publishers Ltd. Axia College. (n.d.). Appendix A: Case studies. Retrieved December 6, 2008, from Axia College, Week Nine, PSY240 - The Brain, the Body, and the Mind. Bailey, L. (1998). Schizophrenia and anti-psychotics. Available from University of Illinois College of Pharmacy. Barbarich-Marstellar, N.C. (2007). Neurochemistry and pharmacological treatments: Where is the field of anorexia nervosa heading?. Central Nervous System Agents in Medicinal Chemistry, 7, 35-43. Retrieved December 9, 2008, from EBSCOhost database. Fear and anxiety: A simultaneous concept analysis (1999). Nursing Diagnosis, 10(3), 103-112. Retrieved December 8, 2008, from CINAHL Plus database. Grohol, J.M. (2008). Schizophrenia treatment. Psych Central. Retrieved December 9, 2008, from http://psychcentral.com/disorders/sx31t.htm Pinel, J.P. (2007). Basics of biopsychology. Boston: Pearson Education. Pinel, J., Assanand, S., & Lehman, D. (2000). Hunger, eating, and ill health. American Psychologist, 55(10), 1105-1116. Retrieved December 10, 2008, from ESBCOhost database.